Where & When

Saturday, October 19, 2024

Detroit Marriott Troy
200 W Big Beaver Rd.
Troy, MI 48084

Download the flyer

Online registration is now closed.

We will ONLY be accepting on-site registration. Registration opens at 7 a.m. Saturday, Oct. 19. Please contact Pam Sydorchuk, symposium coordinator, at 313-576-8746 if you have any questions.

Accreditation

This activity has been approved for AMA PRA Category 1 Credit™ and eligible for 6.00 credits. Provided by Wayne State University School of Medicine and Karmanos Cancer Institute.

Program Director

Dr. Hirva Mamdani

Agenda

7-8 a.m.
Registration and Breakfast

8-8:10 a.m.
Opening Remarks
Hirva Mamdani, M.D., Program Director

8:10-8:35 a.m.
Advances in Diagnostic and Interventional Pulmonary Techniques in Lung Cancer
Khaled Alshabani, M.D.
Assistant Professor
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

8:35-9 a.m.
Perioperative Immunotherapy for Resectable NSCLC
Guest Speaker: Saiama Waqar, M.D., MSCI
Professor of Medicine
Director of Education for Oncology
Research Director for Thoracic Oncology
Washington University School of Medicine
St. Louis, MO

9-9:25 a.m.
Perioperative Targeted Therapy for Resectable NSCLC
Guest Speaker: Antoinette J. Wozniak, M.D., FACP, FASCO
Chief Scientific Officer
Lung Cancer Research Foundation

9:25-9:50 a.m.
Evolving Role of Surgery in the Era of Immunotherapy and Targeted Therapy in Resectable NSCLC
Guest Speaker: Jay M. Lee, M.D.
Associate Professor
Surgical Director, Thoracic Oncology Program
UCLA Health
Los Angeles, California

9:50-10:20 a.m.
Case Presentations and Panel Discussion
Presenter: Khalil Choucair, M.D., MSc
Chief Fellow- Hematology/Oncology
Barbara Ann Karmanos Cancer Institute, Wayne State University
Moderator: Hirva Mamdani, M.D.

10:20-10:40 a.m.
Break

10:40-11:05 a.m.
Expanding Landscape of Small Cell Lung Cancer
Hirva Mamdani, M.D.
Associate Professor
Leader, Thoracic Oncology Multidisciplinary Team
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

11:05-11:35 a.m.
Expanding Landscape of Small Cell Lung Cancer
Hirva Mamdani, M.D.
Associate Professor
Leader, Thoracic Oncology Multidisciplinary Team
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

11:35 a.m.-12:05 p.m.
Treatment of EGFR Positive Locally Advanced and Metastatic NSCLC
Guest Speaker: Jyoti Malhotra, M.D., MPH
Associate Professor
Director, Thoracic Medical Oncology
City of Hope
Duarte, California

12:05-12:45 p.m.
Lunch

12:45-1:10 p.m.
Treatment of Advanced NSCLC Harboring KRAS, HER2, and RET alterations
Dipesh Uprety, M.D., FACP
Assistant Professor
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

1:10-1:35 p.m.
Treatment of Advanced NSCLC Harboring ALK, ROS1, and MET alterations
Tarik Hadid, M.D., MPH, MS, FACP
Associate Professor
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

1:35-1:55 p.m.
Survivorship in Lung Cancer
Morhaf Al Achkar, M.D., Ph.D., MS, FAAFP
Associate Professor
Associate Center Director of Education
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

1:55–2:35 p.m.
Case Presentations and Panel Discussion
Presenter: Khalil Choucair, M.D., MSc
Chief Fellow- Hematology/Oncology
Barbara Ann Karmanos Cancer Institute, Wayne State University
Moderator: Hirva Mamdani, M.D.

2:35- 2:40 p.m.
Closing Remarks
Hirva Mamdani, M.D.

More Information

For any additional questions, please contact Pamela Sydorchuk, symposium coordinator, at symposium@karmanos.org or call 313-576-8746.

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Detroit Cancer Center Unveils New Device for Treating Liver Cancer at Home

The Detroit News The TheraBionic P1 device is now available for patients who have advanced liver cancer and have failed first- and second-line the...

Read More

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

The Barbara Ann Karmanos Cancer Institute , the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announce...

Read More

CURE, in Collaboration with Karmanos' Office of Cancer Health Equity and Community Engagement, Educates the Community About Metastatic Breast Cancer

On Wednesday, Dec. 4, 2024, patients, survivors, and advocates gathered at Karmanos Cancer Institute in Detroit to learn about metastatic breast c...

Read More
News

WDET | Scholarship Program Aims to Encourage More Diversity in Clinical Trials

Listen Now

101 WRIF | Lung Cancer Awareness

Listen Now

Becker’s Healthcare Podcast | Exploring Breakthroughs in Cancer Treatment with Dr. Boris C. Pasche, President & CEO at Karmanos Cancer Institute

Listen Now